The Medical Letter

A nonprofit organization that has been providing independent reviews of drugs and therapeutics since 1959. Funded solely by subscriptions and donations.

[The Medical Letter @MedicalLetter]

Read our latest issue: https://t.co/HxJhTedDyH

#MotionSickness #AlzheimersAgitation #Hypertension

[The Medical Letter @MedicalLetter]

Answer: d
Symptoms of HCM include exertional dyspnea, reduced exercise capacity, chest pain, palpitations, and syncope, but asymptomatic disease is common.

[The Medical Letter @MedicalLetter]

It's Trivia Tuesday! This question is from our article Aficamten (Myqorzo) for Obstructive Hypertrophic Cardiomyopathy https://t.co/dWGtWKYbB3

[The Medical Letter @MedicalLetter]

Read our latest issue: https://t.co/hzFpKJo8YP

#hypercholesterolemia #statins #lipidlowering

[The Medical Letter @MedicalLetter]

It's Trivia Tuesday! This question is from our article Lerodalcibep (Lerochol) for Hypercholesterolemia https://t.co/3j5J6vjho6

Answer: c
Lerodalcibep should be injected into the abdomen or upper front thigh (or the back of the upper arm, if injected by a healthcare provider).

[The Medical Letter @MedicalLetter]

In Brief: An Expanded Indication for Enhertu https://t.co/3UsUPuyJaY

[The Medical Letter @MedicalLetter]

Aficamten (Myqorzo) for Obstructive Hypertrophic Cardiomyopathy https://t.co/dWGtWKYbB3

[The Medical Letter @MedicalLetter]

It's Trivia Tuesday! This question is from our In Brief: RSV Vaccine (Arexvy) for Ages 18-49 https://t.co/foq6TyNc5V

Answer: d
Other risk factors include diabetes, moderate or severe immune compromise, frailty, and residence in a nursing home or other long-term care facility.

[The Medical Letter @MedicalLetter]

Yuvezzi — A Carbachol/Brimonidine Solution for Presbyopia https://t.co/hPT7iDBaCD

[The Medical Letter @MedicalLetter]

Orforglipron (Foundayo) – A Second Oral GLP-1 Receptor Agonist for Weight Loss
https://t.co/OGBmy89hXv

[The Medical Letter @MedicalLetter]

Read our latest issue: https://t.co/HqINm0sQVD

#weightloss #presbyopia #HCM

[The Medical Letter @MedicalLetter]

Relacorilant (Lifyorli) for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer https://t.co/AZzgbfVKZg

[The Medical Letter @MedicalLetter]

Widaplik — Another Three-Drug Combination for Hypertension
Read the Advance Release Article: https://t.co/d0SaGipp5X

[The Medical Letter @MedicalLetter]

In Brief: Vybrique — Sildenafil Oral Film for Erectile Dysfunction https://t.co/rEDCM7Abc2

[The Medical Letter @MedicalLetter]

In Brief: RSV Vaccine (Arexvy) for Ages 18-49 https://t.co/z4QyBgQmbO

[The Medical Letter @MedicalLetter]

In Brief: Wegovy HD – High-Dose Injectable Semaglutide for Weight Loss https://t.co/UMLWNM6xdV

[The Medical Letter @MedicalLetter]

Leucovorin for Cerebral Folate Deficiency https://t.co/No1VFXkwOL

[The Medical Letter @MedicalLetter]

Lerodalcibep (Lerochol) for Hypercholesterolemia https://t.co/3j5J6vjho6

[The Medical Letter @MedicalLetter]

Read our latest issue: https://t.co/KGziH4rHzo

#Hypercholesterolemia #WeightLoss #ErectileDysfunction

[The Medical Letter @MedicalLetter]

It’s Trivia Tuesday! This question is from our In Brief: Ranitidine Returns https://t.co/qmwMWX3SDF

Answer: a
Ranitidine was available OTC before it was withdrawn from the market in 2020, but the new tablet formulation of ranitidine is available only by prescription.